Work

A phase I/II trial to evaluate cabozantinib in patients with advanced hepatocellular carcinoma with Child-Pugh class B cirrhosis after first-line therapy.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.3_suppl.tps357

Authors: Thomas Enzler, Neehar Parikh, Chih-Yi Liao, Aparna Kalyan, David Hsieh, Kent A. Griffith, Vaibhav Sahai

Institutions: University of Michigan, Michigan Medicine, University of Chicago, Northwestern University, The University of Texas Southwestern Medical Center

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Exelixis

OpenAlex ID: W3122820680

Cites:

Cited by:

Related to: 10